Trial Details

TERMINATED
Basic Information
Clinical ID c3085
Identifier NCT02544152
Trial Title Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Irritable Bowel Syndrome
Interventions DRUG: Lubiprostone|DRUG: Placebo
Participant Information
Sponsor Sucampo Pharma Americas, LLC
City Huntsville
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2015-02
Primary Completion Date 2016-12
Completion Date 2016-12